Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?-a narrative review by the international geriatric radiotherapy group.

Translational cancer research(2022)

Cited 1|Views7
No score
Abstract
IGRT and RDCPI may be an innovative option for older patients with locally advanced NSCLC and high PD-L1 expression and needs to be investigated in future prospective studies.
More
Translated text
Key words
Older,cancer patients,image-guided radiotherapy (IGRT),locally advanced,reduced dose for check point inhibitor (RDCPI)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined